FDA clears Viatronix' imaging software for X-ray:
This article was originally published in Clinica
Viatronix has received US FDA 510(k) clearance to broaden the use of its imaging software V3D Explorer to include the evaluation of X-ray images of vital organs. The software, an additional image processing option for the company's V3D visualisation system, can already be used to evaluate CT, MR, PET, and SPECT images. It can now be used to assess images from digital X-ray systems and all forms of digital radiography, says the Stony Brook, New York firm. A multi-purpose 2D and 3D viewing and post processing workstation, the V3D Explorer accepts DICOM compliant images, permitting radiologists to visualise patient's studies in any 2D or 3D projection.
You may also be interested in...
Indoco’s domestic performance picks up pace as the Indian pharma market sees a “bounce back” after a long COVID-induced slump. The Indian company continues to perform well internationally and grow overall.
The MHRA has been working all hours to ensure the standalone medtech UKCA mark works operationally and procedurally in the UK as of 1 January 2021.
Development Partners International, CDC Group and the European Bank for Reconstruction and Development have collaborated to create a “first of its kind, pan-African” generics platform built on the acquisition and combination of Egypt’s Adwia Pharmaceuticals and India’s Celon Laboratories. An initial $250m investment is to be followed by up to $500m in further funding.